Controversy over Effects of Tamiflu Continues

Controversy over Effects of Tamiflu Continues

In a recent report, the department of health has made it clear that patients having fragile immune system must take Tamiflu. Though there are questions raised over the positive effects of the antiviral drug, there are reports recommending the drug for time being.

It has been told that there were glaring reports in the British Medical Journal (BMJ) about the drug reducing the life of patients, though no tangible evidence could be find out. Even a team from the Cochrane Collaboration has peeped into 20 studies concerning the same issue, and claimed that the drug could not reduce the risk related with influenza-related lower respiratory tract complications. As of now, there are no clear cut reports being released for people to follow.

Even pharmaceutical giant Roche is being lashed out for not conducting the study with complete evidence, which has been completely denied by the company. It was told that despite incessant requests to the company, no extended support was given to the current investigators. However, Roche is of the say that they have provided all the available details of the study in the peer-reviewed publications or in summary form on www. roche-trials. com.

Despite the controversy, the UK government is accepting contracts for 50 million doses of Tamiflu. "We cannot be certain whether the trial evidence supports the conclusion that (Tamiflu) reduces complications”, the report said. “Nor do we understand if and how (Tamiflu) changes immune response, and important questions about its mode of action remain”.

It is required that rational decisions are being made after taking into account all possible angles of the underlying theory. Even Dr. Fiona Godlee, Editor-In-Chief of the BMJ has asserted that it would take some more time to actually reach to the conclusion about the drug.

As of now, patients are being given the same drug to beat the risk of flu, but final report concerning the same is awaited.


FrenchTribune Specials

Smoker spends $1.4 million in a lifetime

According to a new report, a smoker is likely to spend a whopping $1.4 million on the nasty habit during his lifetime. The cost includes cost of health problems created or exacerbated by cigarettes, work days lost to those problems and higher homeowner insurance.

Investing the same amount money in the stock market will result in a...

Most Popular

Astronomers discover first "changing look" quasar

A team of astronomers from Yale University have been...

Google persuading Firefox users to ditch Yahoo as their default search engine

In an apparent effort to retain its dominance in the...

BMW, VW team up to install 100 high-speed charging stations in 2015

In an announcement made on Thursday, automakers BMW and...

Property of Over £1bn to Fall into Sea Due to Coastal Erosion

According to an unpublished Environment Agency (EA)...

Poll

Can Greece Come out of Economic Problems: